PRX-105

a PEGylated, plant-derived recombinant form of human read-through acetylcholinesterase splice variant that is used as a bio-scavenger of organophosphorus toxins

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Alon, Sari: 1 article (09/2015)
2.	Atsmon, Jacob: 1 article (09/2015)
3.	Bartfeld, Daniel: 1 article (09/2015)
4.	Ben-Moshe, Tehila: 1 article (09/2015)
5.	Brill-Almon, Einat: 1 article (09/2015)
6.	Chertkoff, Raul: 1 article (09/2015)
7.	Haim, Kirsten Y: 1 article (09/2015)
8.	Nadri-Shay, Carmit: 1 article (09/2015)
9.	Ruderfer, Ilya: 1 article (09/2015)
10.	Shaaltiel, Yoseph: 1 article (09/2015)

Related Diseases

1.	Poisoning 09/15/2015 - "Despite the small number of animals and human subjects who were assessed, the fact that PRX-105 exerts a protective and therapeutic effect following exposure to lethal doses of OP, its favorable safety profile and its relatively long half-life, renders it a promising candidate for treatment and prophylaxis against OP poisoning and warrants further investigation. "

Related Drugs and Biologics

1.	Therapeutic Uses